AstraZeneca and Moderna have presented the interim results of their Phase 3 research. After a long wait, there are now three vaccines in sight instead of one.
The vaccine from Pfizer and BioNTech is 90 percent effective. Today, the companies announced the preliminary results of their phase three trials.
The Belgian company Janssen is starting the final phase of their vaccine research in the United States, South Africa and South America. The Netherlands will also have its turn soon.
The discovery by an international team of scientists can help in the development of new medicines and vaccines.
The vaccine against COVID-19 is designed to enter the cells via the same route as the virus - and thereby activate the immune system.
At the earliest, a vaccine against the novel coronavirus SARS-CoV-2 should be available by next year. At least that’s what medical experts say. However, that’s […]
Research into an active substance for combatting the novel coronavirus SARS-CoV-2 is currently being conducted in laboratories around the world. But could it be that […]
The Austrian start-up Innophore will screen two billion potential active substances for Covid-19. This is the largest computer-based screening project in the world. Collaboration with […]
CEO Intravacc Jan Groen: ‘Development of a vaccine against the Coronavirus will take at least another 1.5 years’
The Coronavirus is killing more and more people, and in the meantime, everyone is hoping for a cure so we can stop worrying about people […]
In a follow up to yesterdays article, the European Union has announced that it is investing €80 million in CureVac, a German biotech company working […]
Update: USA won’t get Corona vaccine via takeover: “Europe is not for sale” – CureVac gets €80 million from EU
One day after we wrote this article (see below) about the fact that biotechnology company Curevac and major shareholder Dietmar Hopp said “no” to a […]